WOOJUNG BIO EBITDA vs. Current Valuation

215380 Stock  KRW 1,621  54.00  3.22%   
Considering WOOJUNG BIO's profitability and operating efficiency indicators, WOOJUNG BIO may not be well positioned to generate adequate gross income at the moment. It has a very high risk of underperforming in January. Profitability indicators assess WOOJUNG BIO's ability to earn profits and add value for shareholders.
For WOOJUNG BIO profitability analysis, we use financial ratios and fundamental drivers that measure the ability of WOOJUNG BIO to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well WOOJUNG BIO utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between WOOJUNG BIO's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of WOOJUNG BIO over time as well as its relative position and ranking within its peers.
  
Check out Trending Equities.
Please note, there is a significant difference between WOOJUNG BIO's value and its price as these two are different measures arrived at by different means. Investors typically determine if WOOJUNG BIO is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, WOOJUNG BIO's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

WOOJUNG BIO Current Valuation vs. EBITDA Fundamental Analysis

Comparative valuation techniques use various fundamental indicators to help in determining WOOJUNG BIO's current stock value. Our valuation model uses many indicators to compare WOOJUNG BIO value to that of its competitors to determine the firm's financial worth.
WOOJUNG BIO is rated fourth in ebitda category among its peers. It also is rated fourth in current valuation category among its peers . Comparative valuation analysis is a catch-all model that can be used if you cannot value WOOJUNG BIO by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for WOOJUNG BIO's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.

WOOJUNG Current Valuation vs. EBITDA

EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital.

WOOJUNG BIO

EBITDA

 = 

Revenue

-

Basic Expenses

 = 
(4.22 B)
In a nutshell, EBITDA is calculated by adding back each of the excluded items to the post-tax profit, and can be used to compare companies with very different capital structures.
Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.

WOOJUNG BIO

Enterprise Value

 = 

Market Cap + Debt

-

Cash

 = 
123.91 B
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.

WOOJUNG Current Valuation vs Competition

WOOJUNG BIO is rated fourth in current valuation category among its peers. After adjusting for long-term liabilities, total market size of Biotechnology & Medical Research industry is presently estimated at about 835.93 Billion. WOOJUNG BIO retains roughly 123.91 Billion in current valuation claiming about 15% of stocks in Biotechnology & Medical Research industry.

WOOJUNG BIO Profitability Projections

The most important aspect of a successful company is its ability to generate a profit. For investors in WOOJUNG BIO, profitability is also one of the essential criteria for including it into their portfolios because, without profit, WOOJUNG BIO will eventually generate negative long term returns. The profitability progress is the general direction of WOOJUNG BIO's change in net profit over the period of time. It can combine multiple indicators of WOOJUNG BIO, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
WOOJUNG BIO, Inc. provides research and laboratory services in Korea. WOOJUNG BIO, Inc. was founded in 1989 and is based in Suwon, South Korea. WOOJUNG BIO is traded on Korean Securities Dealers Automated Quotations in South Korea.

WOOJUNG Profitability Driver Comparison

Profitability drivers are factors that can directly affect your investment outlook on WOOJUNG BIO. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of WOOJUNG BIO position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the WOOJUNG BIO's important profitability drivers and their relationship over time.

Use WOOJUNG BIO in pair-trading

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if WOOJUNG BIO position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in WOOJUNG BIO will appreciate offsetting losses from the drop in the long position's value.

WOOJUNG BIO Pair Trading

WOOJUNG BIO Pair Trading Analysis

The ability to find closely correlated positions to WOOJUNG BIO could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace WOOJUNG BIO when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back WOOJUNG BIO - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling WOOJUNG BIO to buy it.
The correlation of WOOJUNG BIO is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as WOOJUNG BIO moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if WOOJUNG BIO moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for WOOJUNG BIO can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Use Investing Themes to Complement your WOOJUNG BIO position

In addition to having WOOJUNG BIO in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Hotels Thematic Idea Now

Hotels
Hotels Theme
Hotels, inns, motels, and other companies providing lodging and hospitality services. The Hotels theme has 44 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Hotels Theme or any other thematic opportunities.
View All  Next Launch

Other Information on Investing in WOOJUNG Stock

To fully project WOOJUNG BIO's future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of WOOJUNG BIO at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include WOOJUNG BIO's income statement, its balance sheet, and the statement of cash flows.
Potential WOOJUNG BIO investors and stakeholders can use historical trends found within financial statements to determine how well the company is positioned for the future. Although WOOJUNG BIO investors may work on each financial statement separately, they are all related. The changes in WOOJUNG BIO's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on WOOJUNG BIO's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet but not equivalent to net income shown on the income statement. Please read more on our technical analysis and fundamental analysis pages.